Director – Discovery ADME Project Leader (Bioconjugates)
Eli Lilly and Company, Boston, MA, United States
What You Will Do
Keep Safety as a priority.
Develop and implement integrated preclinical ADME strategies aligned with discovery stage, target product profile (TPP), design hypotheses being tested, and regulatory expectations.
As a Bioconjugates ADME Project Leader, bring integrated ADME subject matter expertise, driving comprehensive ADME strategy by aligning pharmacokinetics, metabolism, and mechanistic disposition data with early safety signals; interpret exposure–toxicity relationships, therapeutic index, and off‑target liabilities to proactively de‑risk programs and enable data‑driven candidate selection decisions. Integrate ADME, pharmacology, and toxicology to enable translational simulations and modeling to support dose selection, design of PK/PD, efficacy and safety studies. Define stage‑, modality‑, and issue‑appropriate screening, decision funnels (in silico, in vitro, in vivo to translational modeling). Guide compound design and optimization through data‑driven design principles (clearance, permeability, solubility, DDI risk, transporter liabilities). Serve as the ADME strategy and science single‑point‑of‑accountability on cross‑functional program teams, translating ADME findings into actionable design and test hypotheses. Collaborate closely with Medicinal Chemistry, DMPK, Toxicology, Pharmacology, and other Discovery Functions to drive high quality candidate selections. Contribute to go
o‑go decisions using quantitative PK/PD, IVIVE, and mechanistic interpretation. Represent ADME in portfolio governance discussions and leadership reviews. Implement best practices, assay innovation, and automation where appropriate. Drive continuous improvement in data reporting, knowledge management, and decision frameworks. Seek and leverage AI and agentic tools where possible to pipeline data, interpret data and share results. Maintain inspection‑ready documentation and alignment with regulatory expectations. Mentor, teach and grow junior scientists and contribute to functional capability building.
Basic Qualifications
PhD in Pharmaceutical Sciences, Pharmacokinetics, Pharmacometrics, Systems Pharmacology, Preclinical or Clinical Pharmacology, Drug Metabolism, Toxicology, Chemical Biology, or related field or Bachelor's with 10+ years experience.
6+ years of post‑graduation industry experience in a drug discovery environment, driving discovery teams with understanding of the life cycle/flywheel (Design, Make, Test, Analyze) of a discovery project.
Additional Skill/Preferences
Deep subject matter ADME expertise, a working knowledge of medicinal chemistry and bioconjugates.
Exceptional written and verbal communication skills; ability to successfully navigate ambiguity and/or global cross‑functional collaborations.
Demonstrated ability to translate complex technical concepts into strategic value for senior leadership and cross‑functional partners.
Lilly is proud to be an EEO Employer and does not discriminate on the basis of age, race, color, religion, gender identity, sex, gender expression, sexual orientation, genetic information, ancestry, national origin, protected veteran status, disability, or any other legally protected status.
Actual compensation will depend on a candidate’s education, experience, skills, and geographic location. The anticipated wage for this position is
$177,000 - $308,000 .
Full‑time equivalent employees also will be eligible for a company bonus (depending, in part, on company and individual performance). In addition, Lilly offers a comprehensive benefit program to eligible employees, including eligibility to participate in a company‑sponsored 401(k); pension; vacation benefits; eligibility for medical, dental, vision and prescription drug benefits; flexible benefits (e.g., healthcare and/or dependent day care flexible spending accounts); life insurance and death benefits; certain time off and leave of absence benefits; and well‑being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities). Lilly reserves the right to amend, modify, or terminate its compensation and benefit programs in its sole discretion and Lilly’s compensation practices and guidelines will apply regarding the details of any promotion or transfer of Lilly employees.
#J-18808-Ljbffr
Keep Safety as a priority.
Develop and implement integrated preclinical ADME strategies aligned with discovery stage, target product profile (TPP), design hypotheses being tested, and regulatory expectations.
As a Bioconjugates ADME Project Leader, bring integrated ADME subject matter expertise, driving comprehensive ADME strategy by aligning pharmacokinetics, metabolism, and mechanistic disposition data with early safety signals; interpret exposure–toxicity relationships, therapeutic index, and off‑target liabilities to proactively de‑risk programs and enable data‑driven candidate selection decisions. Integrate ADME, pharmacology, and toxicology to enable translational simulations and modeling to support dose selection, design of PK/PD, efficacy and safety studies. Define stage‑, modality‑, and issue‑appropriate screening, decision funnels (in silico, in vitro, in vivo to translational modeling). Guide compound design and optimization through data‑driven design principles (clearance, permeability, solubility, DDI risk, transporter liabilities). Serve as the ADME strategy and science single‑point‑of‑accountability on cross‑functional program teams, translating ADME findings into actionable design and test hypotheses. Collaborate closely with Medicinal Chemistry, DMPK, Toxicology, Pharmacology, and other Discovery Functions to drive high quality candidate selections. Contribute to go
o‑go decisions using quantitative PK/PD, IVIVE, and mechanistic interpretation. Represent ADME in portfolio governance discussions and leadership reviews. Implement best practices, assay innovation, and automation where appropriate. Drive continuous improvement in data reporting, knowledge management, and decision frameworks. Seek and leverage AI and agentic tools where possible to pipeline data, interpret data and share results. Maintain inspection‑ready documentation and alignment with regulatory expectations. Mentor, teach and grow junior scientists and contribute to functional capability building.
Basic Qualifications
PhD in Pharmaceutical Sciences, Pharmacokinetics, Pharmacometrics, Systems Pharmacology, Preclinical or Clinical Pharmacology, Drug Metabolism, Toxicology, Chemical Biology, or related field or Bachelor's with 10+ years experience.
6+ years of post‑graduation industry experience in a drug discovery environment, driving discovery teams with understanding of the life cycle/flywheel (Design, Make, Test, Analyze) of a discovery project.
Additional Skill/Preferences
Deep subject matter ADME expertise, a working knowledge of medicinal chemistry and bioconjugates.
Exceptional written and verbal communication skills; ability to successfully navigate ambiguity and/or global cross‑functional collaborations.
Demonstrated ability to translate complex technical concepts into strategic value for senior leadership and cross‑functional partners.
Lilly is proud to be an EEO Employer and does not discriminate on the basis of age, race, color, religion, gender identity, sex, gender expression, sexual orientation, genetic information, ancestry, national origin, protected veteran status, disability, or any other legally protected status.
Actual compensation will depend on a candidate’s education, experience, skills, and geographic location. The anticipated wage for this position is
$177,000 - $308,000 .
Full‑time equivalent employees also will be eligible for a company bonus (depending, in part, on company and individual performance). In addition, Lilly offers a comprehensive benefit program to eligible employees, including eligibility to participate in a company‑sponsored 401(k); pension; vacation benefits; eligibility for medical, dental, vision and prescription drug benefits; flexible benefits (e.g., healthcare and/or dependent day care flexible spending accounts); life insurance and death benefits; certain time off and leave of absence benefits; and well‑being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities). Lilly reserves the right to amend, modify, or terminate its compensation and benefit programs in its sole discretion and Lilly’s compensation practices and guidelines will apply regarding the details of any promotion or transfer of Lilly employees.
#J-18808-Ljbffr